MISONIX, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 9 rows in 2021. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-06-30: Reporting owner Waggoner Jonathan Jay; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-30: Reporting owner PATTON THOMAS M; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-30: Reporting owner Vizirgianakis Stavros G.; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-30: Reporting owner Koby Michael; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | Waggoner Jonathan Jay Officer (SVP, Wound Sales) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-06-30 | PATTON THOMAS M Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-06-30 | Vizirgianakis Stavros G. Director, Officer (CEO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-06-30 | Koby Michael Director | 4 | Stock Option Derivative · Indirect · By 1315 Capital Management, LLC | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-06-30 | Klugewicz Sharon W Director, Officer (Chief Operating Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-06-30 | LAVIOLETTE PAUL A Director | 4 | Stock Option Derivative · Indirect · By SV Health Investors, LLC | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-06-30 | Ludecker Robert S Officer (SVP Sales - Surgical) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-06-30 | Dwyer Joseph P Officer (Chief Financial Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $22.18 exercise price | 2021-07-02 | |
| 2021-05-14 | Beyer Pat Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $19.09 exercise price | 2021-05-18 |